全文获取类型
收费全文 | 2306篇 |
免费 | 210篇 |
国内免费 | 4篇 |
出版年
2022年 | 27篇 |
2021年 | 33篇 |
2020年 | 18篇 |
2019年 | 24篇 |
2018年 | 28篇 |
2017年 | 18篇 |
2016年 | 46篇 |
2015年 | 94篇 |
2014年 | 117篇 |
2013年 | 98篇 |
2012年 | 175篇 |
2011年 | 141篇 |
2010年 | 95篇 |
2009年 | 74篇 |
2008年 | 133篇 |
2007年 | 120篇 |
2006年 | 129篇 |
2005年 | 108篇 |
2004年 | 90篇 |
2003年 | 95篇 |
2002年 | 77篇 |
2001年 | 72篇 |
2000年 | 61篇 |
1999年 | 34篇 |
1998年 | 21篇 |
1997年 | 21篇 |
1996年 | 22篇 |
1995年 | 14篇 |
1994年 | 22篇 |
1993年 | 12篇 |
1992年 | 27篇 |
1991年 | 32篇 |
1990年 | 22篇 |
1989年 | 34篇 |
1988年 | 34篇 |
1987年 | 31篇 |
1986年 | 33篇 |
1985年 | 33篇 |
1984年 | 19篇 |
1983年 | 25篇 |
1982年 | 19篇 |
1981年 | 16篇 |
1980年 | 12篇 |
1979年 | 23篇 |
1978年 | 14篇 |
1977年 | 25篇 |
1976年 | 14篇 |
1975年 | 11篇 |
1974年 | 12篇 |
1973年 | 17篇 |
排序方式: 共有2520条查询结果,搜索用时 15 毫秒
101.
Xiaoyu Yang Wei Xu Svetlana Dukleska Sabrina Benchaar Selina Mengisen Valentyn Antochshuk Jason Cheung Leslie Mann Zulfia Babadjanova Jason Rowand Rico Gunawan Alexander McCampbell Maribel Beaumont David Meininger Daisy Richardson Alexandre Ambrogelly 《MABS-AUSTIN》2013,5(5):787-794
Monoclonal antibodies constitute a robust class of therapeutic proteins. Their stability, resistance to stress conditions and high solubility have allowed the successful development and commercialization of over 40 antibody-based drugs. Although mAbs enjoy a relatively high probability of success compared with other therapeutic proteins, examples of projects that are suspended due to the instability of the molecule are not uncommon. Developability assessment studies have therefore been devised to identify early during process development problems associated with stability, solubility that is insufficient to meet expected dosing or sensitivity to stress. This set of experiments includes short-term stability studies at 2−8 þC, 25 þC and 40 þC, freeze-thaw studies, limited forced degradation studies and determination of the viscosity of high concentration samples. We present here three case studies reflecting three typical outcomes: (1) no major or unexpected degradation is found and the study results are used to inform early identification of degradation pathways and potential critical quality attributes within the Quality by Design framework defined by US Food and Drug Administration guidance documents; (2) identification of specific degradation pathway(s) that do not affect potency of the molecule, with subsequent definition of proper process control and formulation strategies; and (3) identification of degradation that affects potency, resulting in program termination and reallocation of resources. 相似文献
102.
Gianpiero Di Leva Claudia Piovan Pierluigi Gasparini Apollinaire Ngankeu Cristian Taccioli Daniel Briskin Douglas G. Cheung Brad Bolon Laura Anderlucci Hansjuerg Alder Gerard Nuovo Meng Li Marilena V. Iorio Marco Galasso Santhanam Ramasamy Guido Marcucci Danilo Perrotti Kimerly A. Powell Anna Bratasz Michela Garofalo Kenneth P. Nephew Carlo M. Croce 《PLoS genetics》2013,9(3)
103.
104.
Three different types of biocides, viz. formaldehyde (FM), glutaraldehyde (GA) and isothiozolone (ITZ) were used to control planktonic and sessile populations of two marine isolates of sulphate‐reducing bacteria (SRB). The influence of these biocides on the initial attachment of cells to mild steel surfaces, on subsequent biofilm formation and on the activity of hydrogenase enzymes within developed biofilms was evaluated. In the presence of biocides the rate and degree of colonization of mild steel by SRB depended on incubation time, bacterial isolate and the type of biocide used. Although SRB differed in their susceptibility to biocides, for all isolates the biofilm population was more resistant to the treatment than the planktonic population. GA showed highest efficiency in controlling planktonic and sessile SRB compared with the other two biocides. The activity of the enzyme hydrogenase measured in SRB biofilms varied between isolates and with the biocide treatment. No correlation was found between the number of sessile cells and hydrogenase activity. 相似文献
105.
M. Iqbal Hossain Carli L. Roulston M. Aizuddin Kamaruddin Percy W. Y. Chu Dominic C. H. Ng Gregory J. Dusting Jeffrey D. Bjorge Nicholas A. Williamson Donald J. Fujita Steve N. Cheung Tung O. Chan Andrew F. Hill Heung-Chin Cheng 《The Journal of biological chemistry》2013,288(14):9696-9709
Excitotoxicity resulting from overstimulation of glutamate receptors is a major cause of neuronal death in cerebral ischemic stroke. The overstimulated ionotropic glutamate receptors exert their neurotoxic effects in part by overactivation of calpains, which induce neuronal death by catalyzing limited proteolysis of specific cellular proteins. Here, we report that in cultured cortical neurons and in vivo in a rat model of focal ischemic stroke, the tyrosine kinase Src is cleaved by calpains at a site in the N-terminal unique domain. This generates a truncated Src fragment of ∼52 kDa, which we localized predominantly to the cytosol. A cell membrane-permeable fusion peptide derived from the unique domain of Src prevents calpain from cleaving Src in neurons and protects against excitotoxic neuronal death. To explore the role of the truncated Src fragment in neuronal death, we expressed a recombinant truncated Src fragment in cultured neurons and examined how it affects neuronal survival. Expression of this fragment, which lacks the myristoylation motif and unique domain, was sufficient to induce neuronal death. Furthermore, inactivation of the prosurvival kinase Akt is a key step in its neurotoxic signaling pathway. Because Src maintains neuronal survival, our results implicate calpain cleavage as a molecular switch converting Src from a promoter of cell survival to a mediator of neuronal death in excitotoxicity. Besides unveiling a new pathological action of Src, our discovery of the neurotoxic action of the truncated Src fragment suggests new therapeutic strategies with the potential to minimize brain damage in ischemic stroke. 相似文献
106.
Yee?Him Cheung Tenzin Gayden Philippe?M. Campeau Charles?A. LeDuc Donna Russo Van-Hung Nguyen Jiancheng Guo Ming Qi Yanfang Guan Steffen Albrecht Brenda Moroz Karen?W. Eldin James?T. Lu Jeremy Schwartzentruber David Malkin Albert?M. Berghuis Sherif Emil Richard?A. Gibbs David?L. Burk Megan Vanstone Brendan?H. Lee David Orchard Kym?M. Boycott Wendy?K. Chung Nada Jabado 《American journal of human genetics》2013,92(6):996-1000
Infantile myofibromatosis (IM) is the most common benign fibrous tumor of soft tissues affecting young children. By using whole-exome sequencing, RNA sequencing, and targeted sequencing, we investigated germline and tumor DNA in individuals from four distinct families with the familial form of IM and in five simplex IM cases with no previous family history of this disease. We identified a germline mutation c.1681C>T (p.Arg561Cys) in platelet-derived growth factor receptor β (PDGFRB) in all 11 affected individuals with familial IM, although none of the five individuals with nonfamilial IM had mutations in this gene. We further identified a second heterozygous mutation in PDGFRB in two myofibromas from one of the affected familial cases, indicative of a potential second hit in this gene in the tumor. PDGFR-β promotes growth of mesenchymal cells, including blood vessels and smooth muscles, which are affected in IM. Our findings indicate p.Arg561Cys substitution in PDGFR-β as a cause of the dominant form of this disease. They provide a rationale for further investigations of this specific mutation and gene to assess the benefits of targeted therapies against PDGFR-β in aggressive life-threatening familial forms of the disease. 相似文献
107.
108.
109.
110.
Gabrielle K. Y. Lee Harry H. X. Wang Kirin Q. L. Liu Yu Cheung Donald E. Morisky Martin C. S. Wong 《PloS one》2013,8(4)